Literature DB >> 7494910

Clinical applications of serum markers for lung cancer.

D Ferrigno1, G Buccheri.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7494910     DOI: 10.1016/0954-6111(95)90225-2

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


× No keyword cloud information.
  6 in total

1.  Squamous cell carcinoma antigen in lung cancer and nonmalignant respiratory diseases.

Authors:  Katsunori Kagohashi; Hiroaki Satoh; Koichi Kurishima; Kennosuke Kadono; Hiroichi Ishikawa; Morio Ohtsuka; Kiyohisa Sekizawa
Journal:  Lung       Date:  2008-07-29       Impact factor: 2.584

2.  Significance of tumor markers in lung cancer.

Authors:  P P Mumbarkar; A S Raste; M S Ghadge
Journal:  Indian J Clin Biochem       Date:  2006-03

3.  Chromogranin A, a significant prognostic factor in small cell lung cancer.

Authors:  L Drivsholm; L I Paloheimo; K Osterlind
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

Review 4.  Biosensors Incorporating Bimetallic Nanoparticles.

Authors:  John Rick; Meng-Che Tsai; Bing Joe Hwang
Journal:  Nanomaterials (Basel)       Date:  2015-12-31       Impact factor: 5.076

Review 5.  Prognostic value of soluble major histocompatibility complex class I polypeptide-related sequence A in non-small-cell lung cancer - significance and development.

Authors:  Roberto Cascone; Annalisa Carlucci; Matteo Pierdiluca; Mario Santini; Alfonso Fiorelli
Journal:  Lung Cancer (Auckl)       Date:  2017-10-10

6.  Tandem mass spectrometry-based newborn screening strategy could be used to facilitate rapid and sensitive lung cancer diagnosis.

Authors:  Ting Huang; Yunfeng Cao; Jia Zeng; Jun Dong; Xiaoyu Sun; Jianxing Chen; Peng Gao
Journal:  Onco Targets Ther       Date:  2016-04-26       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.